AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-79
Results: 1-25/79
DIAGNOSING CENTRAL-NERVOUS-SYSTEM LYMPHOMA IN THE SETTING OF AIDS - ASTEP FORWARD
Authors: YARCHOAN R JAFFE ES LITTLE R
Citation: R. Yarchoan et al., DIAGNOSING CENTRAL-NERVOUS-SYSTEM LYMPHOMA IN THE SETTING OF AIDS - ASTEP FORWARD, Journal of the National Cancer Institute, 90(5), 1998, pp. 346-347
HUMAN-HERPESVIRUS-8 (HHV-8) IN THE PATHOGENESIS OF KAPOSIS-SARCOMA AND OTHER DISEASES
Authors: HUMPHREY RW DAVIS DA NEWCOMB FM YARCHOAN R
Citation: Rw. Humphrey et al., HUMAN-HERPESVIRUS-8 (HHV-8) IN THE PATHOGENESIS OF KAPOSIS-SARCOMA AND OTHER DISEASES, Leukemia & lymphoma, 28(3-4), 1998, pp. 255-264
INACTIVATION OF HIV-1 AND HIV-2 PROTEASES THROUGH OXIDATIVE MODIFICATION
Authors: DAVIS DA NEWCOMB FM MOSKOVITZ J WINGFIELD PT KAUFMANN J STAHL SJ FALES HM LEVINE RL YARCHOAN R
Citation: Da. Davis et al., INACTIVATION OF HIV-1 AND HIV-2 PROTEASES THROUGH OXIDATIVE MODIFICATION, Free radical biology & medicine, 25, 1998, pp. 204-204
THE CHALLENGE OF DESIGNING CLINICAL-TRIALS FOR AIDS-RELATED KAPOSIS-SARCOMA
Authors: LITTLE RF PLUDA JM FEIGAL E YARCHOAN R
Citation: Rf. Little et al., THE CHALLENGE OF DESIGNING CLINICAL-TRIALS FOR AIDS-RELATED KAPOSIS-SARCOMA, Oncology, 12(6), 1998, pp. 871
PHASE-II TRIAL WITH DOSE TITRATION OF PACLITAXEL FOR THE THERAPY OF HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED KAPOSIS-SARCOMA
Authors: WELLES L SAVILLE MW LIETZAU J PLUDA JM WYVILL KM FEUERSTEIN I FIGG WD LUSH R ODOM J WILSON WH FAJARDO MT HUMPHREY RW FEIGAL E TUCK D STEINBERG SM BRODER S YARCHOAN R
Citation: L. Welles et al., PHASE-II TRIAL WITH DOSE TITRATION OF PACLITAXEL FOR THE THERAPY OF HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED KAPOSIS-SARCOMA, Journal of clinical oncology, 16(3), 1998, pp. 1112-1121
PILOT-STUDY OF THE IMMUNOLOGICAL EFFECTS OF RECOMBINANT HUMAN GROWTH-HORMONE AND RECOMBINANT INSULIN-LIKE-GROWTH-FACTOR IN HIV-INFECTED PATIENTS
Authors: NGUYEN BY CLERICI M VENZON DJ BAUZA S MURPHY WJ LONGO DL BASELER M GESUNDHEIT N BRODER S SHEARER G YARCHOAN R
Citation: By. Nguyen et al., PILOT-STUDY OF THE IMMUNOLOGICAL EFFECTS OF RECOMBINANT HUMAN GROWTH-HORMONE AND RECOMBINANT INSULIN-LIKE-GROWTH-FACTOR IN HIV-INFECTED PATIENTS, AIDS, 12(8), 1998, pp. 895-904
GLYCOCALICIN LEVELS IN THE PLASMA OF HIV- AN INDICATOR OF PLATELET TURNOVER( PATIENTS )
Authors: WILLIAMS SB SANO M SMITH N HORNE M YARCHOAN R WYVILL K ZEICHNER S TAYLOR P KNUDSON T GRALNICK HR
Citation: Sb. Williams et al., GLYCOCALICIN LEVELS IN THE PLASMA OF HIV- AN INDICATOR OF PLATELET TURNOVER( PATIENTS ), The Journal of laboratory and clinical medicine, 132(4), 1998, pp. 303-307
RELATIVE POTENCY OF PROTEASE INHIBITORS IN MONOCYTES MACROPHAGES ACUTELY AND CHRONICALLY INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS/
Authors: PERNO CF NEWCOMB FM DAVIS DA AQUARO S HUMPHREY RW CALIO R YARCHOAN R
Citation: Cf. Perno et al., RELATIVE POTENCY OF PROTEASE INHIBITORS IN MONOCYTES MACROPHAGES ACUTELY AND CHRONICALLY INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS/, The Journal of infectious diseases, 178(2), 1998, pp. 413-422
EMERGENCE OF MULTI-DIDEOXYNUCLEOSIDE-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS, VIRAL SEQUENCE VARIATION, AND DISEASE PROGRESSION IN PATIENTS RECEIVING ANTIRETROVIRAL CHEMOTHERAPY
Authors: KAVLICK MF WYVILL K YARCHOAN R MITSUYA H
Citation: Mf. Kavlick et al., EMERGENCE OF MULTI-DIDEOXYNUCLEOSIDE-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS, VIRAL SEQUENCE VARIATION, AND DISEASE PROGRESSION IN PATIENTS RECEIVING ANTIRETROVIRAL CHEMOTHERAPY, The Journal of infectious diseases, 177(6), 1998, pp. 1506-1513
OPTIMIZING COMBINATION CHEMOTHERAPY FOR KAPOSIS-SARCOMA
Authors: YARCHOAN R LITTLE R
Citation: R. Yarchoan et R. Little, OPTIMIZING COMBINATION CHEMOTHERAPY FOR KAPOSIS-SARCOMA, The cancer journal from Scientific American, 3(5), 1997, pp. 268-270
A PHASE-I TRIAL ADMINISTERING THE ANGIOGENESIS INHIBITOR TNP-470 (AGM-1470) TO PATIENTS (PTS) WITH HIV-ASSOCIATED KAPOSIS-SARCOMA (KS)
Authors: PLUDA JM WYVILL KK LIETZAU J FIGG WD WHITCUP SM FEIGAL E HUMPHREY R WELLES L YARCHOAN R
Citation: Jm. Pluda et al., A PHASE-I TRIAL ADMINISTERING THE ANGIOGENESIS INHIBITOR TNP-470 (AGM-1470) TO PATIENTS (PTS) WITH HIV-ASSOCIATED KAPOSIS-SARCOMA (KS), Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 13-13
PRELIMINARY-RESULTS OF A PHASE-II STUDY OF ORAL THALIDOMIDE IN PATIENTS WITH HIV-INFECTION AND KAPOSIS-SARCOMA (KS)
Authors: WELLES L LITTLE R WYVILL K PLUDA J FIGG W LIETZAU J MERCED T HUMPHREY R YARCHOAN R
Citation: L. Welles et al., PRELIMINARY-RESULTS OF A PHASE-II STUDY OF ORAL THALIDOMIDE IN PATIENTS WITH HIV-INFECTION AND KAPOSIS-SARCOMA (KS), Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 20-20
KAPOSIS-SARCOMA RESPONSE CRITERIA - ISSUES IDENTIFIED BY THE NATIONAL-CANCER-INSTITUTE, FOOD-AND-DRUG-ADMINISTRATION, AND THE AIDS-MALIGNANCY-CONSORTIUM
Authors: FEIGAL EG VONROENN J JUSTICE R YARCHOAN R KROWN S PLUDA J ARBUCK S MURGO A MCCABE M UNGERLEIDER R WITTES R
Citation: Eg. Feigal et al., KAPOSIS-SARCOMA RESPONSE CRITERIA - ISSUES IDENTIFIED BY THE NATIONAL-CANCER-INSTITUTE, FOOD-AND-DRUG-ADMINISTRATION, AND THE AIDS-MALIGNANCY-CONSORTIUM, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 24-24
ISOLATION OF HUMAN HERPESVIRUS-8 (HHV-8) FROM PBMC OF AIDS-KS PATIENTS AND VIRAL TRANSMISSION TO PRIMARY-CELL CULTURE
Authors: COLOMBINIHATCH S TRWNISZEWSKA E RAMAZZONI E RIVARDENEIRA E YARCHOAN R HUMPHREY R ENSOLI B GALLO RC
Citation: S. Colombinihatch et al., ISOLATION OF HUMAN HERPESVIRUS-8 (HHV-8) FROM PBMC OF AIDS-KS PATIENTS AND VIRAL TRANSMISSION TO PRIMARY-CELL CULTURE, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 72-72
ANALYSIS OF HUMAN HERPESVIRUS-8 INFECTION IN CHILDREN AND ADULTS BY MEASURING SERUM ANTIBODIES TO A PEPTIDE OF A MINOR CAPSID PROTEIN OR BYPCR
Authors: HUMPHREY RW DAVIS DA NEWCOMB FM OBRIEN TR GOEDERT JJ STRAUS SE PASS R YARCHOAN R
Citation: Rw. Humphrey et al., ANALYSIS OF HUMAN HERPESVIRUS-8 INFECTION IN CHILDREN AND ADULTS BY MEASURING SERUM ANTIBODIES TO A PEPTIDE OF A MINOR CAPSID PROTEIN OR BYPCR, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 74-74
HIV VIRAL BURDEN (VB) DURING EPOCH CHEMOTHERAPY (CT) FOR HIV-RELATED LYMPHOMAS
Authors: LITTLE R FRANCHINI G PEARSON D ELWOOD P STEINBERG S YARCHOAN R WILSON WH
Citation: R. Little et al., HIV VIRAL BURDEN (VB) DURING EPOCH CHEMOTHERAPY (CT) FOR HIV-RELATED LYMPHOMAS, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 104-104
GLUTATHIONYLATED FORMS OF THE HIV-1 PROTEASE ARE SUBSTRATES FOR HUMANTHIOLTRANSFERASE (GLUTAREDOXIN), AN ENZYME ALSO DETECTED IN HIV-1 VIRIONS
Authors: DAVIS DA NEWCOMB FM STARKE DW OTT DE MIEYAL JJ YARCHOAN R
Citation: Da. Davis et al., GLUTATHIONYLATED FORMS OF THE HIV-1 PROTEASE ARE SUBSTRATES FOR HUMANTHIOLTRANSFERASE (GLUTAREDOXIN), AN ENZYME ALSO DETECTED IN HIV-1 VIRIONS, The FASEB journal, 11(9), 1997, pp. 735-735
EFFECTS OF HUMAN-IMMUNODEFICIENCY-VIRUS AND COLONY-STIMULATING FACTORS ON THE PRODUCTION OF INTERLEUKIN-6 AND TUMOR-NECROSIS-FACTOR-ALPHA BY MONOCYTE MACROPHAGES/
Authors: FOLI A SAVILLE MW MAY LT WEBB DSA YARCHOAN R
Citation: A. Foli et al., EFFECTS OF HUMAN-IMMUNODEFICIENCY-VIRUS AND COLONY-STIMULATING FACTORS ON THE PRODUCTION OF INTERLEUKIN-6 AND TUMOR-NECROSIS-FACTOR-ALPHA BY MONOCYTE MACROPHAGES/, AIDS research and human retroviruses, 13(10), 1997, pp. 829-839
THE PHARMACOKINETICS OF TNP-470, A NEW ANGIOGENESIS INHIBITOR
Authors: FIGG WD PLUDA JM LUSH RM SAVILLE MW WYVILL K REED E YARCHOAN R
Citation: Wd. Figg et al., THE PHARMACOKINETICS OF TNP-470, A NEW ANGIOGENESIS INHIBITOR, Pharmacotherapy, 17(1), 1997, pp. 91-97
EFFECT OF COMBINATION THERAPY WITH ZIDOVUDINE AND DIDANOSINE ON NEUROPSYCHOLOGICAL FUNCTIONING IN PATIENTS WITH SYMPTOMATIC HIV DISEASE - ACOMPARISON OF SIMULTANEOUS AND ALTERNATING REGIMENS
Authors: BROUWERS P HENDRICKS M LIETZAU JA PLUDA JM MITSUYA H BRODER S YARCHOAN R
Citation: P. Brouwers et al., EFFECT OF COMBINATION THERAPY WITH ZIDOVUDINE AND DIDANOSINE ON NEUROPSYCHOLOGICAL FUNCTIONING IN PATIENTS WITH SYMPTOMATIC HIV DISEASE - ACOMPARISON OF SIMULTANEOUS AND ALTERNATING REGIMENS, AIDS, 11(1), 1997, pp. 59-66
REMOVAL OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) PROTEASE INHIBITORS FROM PREPARATIONS OF IMMATURE HIV-1 VIRIONS DOES NOT RESULT IN AN INCREASE IN INFECTIVITY OR THE APPEARANCE OF MATURE MORPHOLOGY
Authors: HUMPHREY RW OHAGEN A DAVIS DA FUKAZAWA T HAYASHI H HOGLUND S MITSUYA H YARCHOAN R
Citation: Rw. Humphrey et al., REMOVAL OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) PROTEASE INHIBITORS FROM PREPARATIONS OF IMMATURE HIV-1 VIRIONS DOES NOT RESULT IN AN INCREASE IN INFECTIVITY OR THE APPEARANCE OF MATURE MORPHOLOGY, Antimicrobial agents and chemotherapy, 41(5), 1997, pp. 1017-1023
DETECTION OF SERUM ANTIBODIES TO A KAPOSIS SARCOMA-ASSOCIATED HERPESVIRUS-SPECIFIC PEPTIDE
Authors: DAVIS DA HUMPHREY RW NEWCOMB FM OBRIEN TR GOEDERT JJ STRAUS SE YARCHOAN R
Citation: Da. Davis et al., DETECTION OF SERUM ANTIBODIES TO A KAPOSIS SARCOMA-ASSOCIATED HERPESVIRUS-SPECIFIC PEPTIDE, The Journal of infectious diseases, 175(5), 1997, pp. 1071-1079
PRODUCTIVE INFECTION OF DENDRITIC CELLS BY HIV-1 AND THEIR ABILITY TOCAPTURE VIRUS ARE MEDIATED THROUGH SEPARATE PATHWAYS
Authors: BLAUVELT A ASADA H SAVILLE MW KLAUSKOVTUN V ALTMAN DJ YARCHOAN R KATZ SI
Citation: A. Blauvelt et al., PRODUCTIVE INFECTION OF DENDRITIC CELLS BY HIV-1 AND THEIR ABILITY TOCAPTURE VIRUS ARE MEDIATED THROUGH SEPARATE PATHWAYS, The Journal of clinical investigation, 100(8), 1997, pp. 2043-2053
THIOLTRANSFERASE (GLUTAREDOXIN) IS DETECTED-WITHIN HIV-1 AND CAN REGULATE THE ACTIVITY OF GLUTATHIONYLATED HIV-1 PROTEASE IN-VITRO
Authors: DAVIS DA NEWCOMB FM STARKE DW OTT DE MIEYAL JJ YARCHOAN R
Citation: Da. Davis et al., THIOLTRANSFERASE (GLUTAREDOXIN) IS DETECTED-WITHIN HIV-1 AND CAN REGULATE THE ACTIVITY OF GLUTATHIONYLATED HIV-1 PROTEASE IN-VITRO, The Journal of biological chemistry, 272(41), 1997, pp. 25935-25940
HIV VIRIONS PRODUCED BY CELLS TREATED WITH THE HIV-1 PROTEASE INHIBITOR KNI-272 DO NOT ACQUIRE INFECTIVITY AFTER VIRAL BUDDING
Authors: HUMPHREY RW DAVIS DA MITSUYA H YARCHOAN R
Citation: Rw. Humphrey et al., HIV VIRIONS PRODUCED BY CELLS TREATED WITH THE HIV-1 PROTEASE INHIBITOR KNI-272 DO NOT ACQUIRE INFECTIVITY AFTER VIRAL BUDDING, Journal of investigative medicine, 44(3), 1996, pp. 252-252
Risultati: 1-25 | 26-50 | 51-75 | 76-79